Aspirin: 120 years of innovation. A report from the 2017 Scientific Conference of the International Aspirin Foundation, 14 September 2017,Charité, Berlin

Jaqui Walker; Pippa Hutchison; Junbo Ge; Dong Zhao; Yongjun Wang; Peter M. Rothwell; J. Michael Gaziano; Andrew Chan; John Burn; John Chia; Ruth Langley; Valerie O'Donnell; Bianca Rocca; Chris Hawkey

doi:10.3332/ecancer.2018.813

Aspirin: 120 years of innovation. A report from the 2017 Scientific Conference of the International Aspirin Foundation, 14 September 2017,Charité, Berlin

Jaqui Walker^*
, Pippa Hutchison
, Junbo Ge
, Dong Zhao
, Yongjun Wang
, Peter M. Rothwell
, J. Michael Gaziano
, Andrew Chan
, John Burn
, John Chia
, Ruth Langley
, Valerie O'Donnell
, Bianca Rocca
, Chris Hawkey

^*Autore corrispondente per questo lavoro

Facoltà di Medicina e Chirurgia "A.Gemelli"

International Aspirin Foundation
Shanghai Institute of Cardiovascular Diseases
Fudan University
Beijing Institute of Heart Lung and Blood Vessel Diseases
Capital Medical University
University of Oxford
Massachusetts Veterans Epidemiology and Information Center
Harvard University
National Cancer Centre
University College London
University Hospitals Sussex NHS Foundation Trust
Cardiff University
University of Nottingham

Risultato della ricerca: Contributo in rivista › Articolo › peer review

2 Citazioni (Scopus)

Abstract

Acetylsalicylic acid was first synthesised by Dr FeIix Hoffman on 10th August 1897 and Aspirin was born. It quickly became the best-known pain killer in the world and in the 120 years since this event, aspirin has continued to attract interest, innovation and excitement. Set within the walls of the preserved ruins of Rudolf Virchow's lecture hall at Charité, within Berlin's Museum of Medical History, the International Aspirin Foundation's 28th Scientific Conference served to facilitate international, multi-disease, multidisciplinary discussion about the current understanding of aspirin's mechanisms of action and its utility in modern medicine as well as ideas for future research into its multifaceted applications to enhance global health.

Lingua originale	Inglese
pagine (da-a)	813-820
Numero di pagine	8
Rivista	ecancermedicalscience
Volume	12
Numero di pubblicazione	Feb 20
DOI	https://doi.org/10.3332/ecancer.2018.813
Stato di pubblicazione	Pubblicato - 2018

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

SDG 3 Salute e benessere

All Science Journal Classification (ASJC) codes

Oncologia
Ricerca sul Cancro

Keywords

Cancer Research
Lynch syndrome
Oncology
aspirin
benefit
bleeding
cardiovascular disease (CVD)
colorectal cancer (CRC)
individualised choice
inflammation
personalised medicine
precision medicine
primary prevention
risk
secondary prevention
stroke
tertiary prevention

Accesso al documento

10.3332/ecancer.2018.813

Altri file e collegamenti

Cita questo

Walker, J., Hutchison, P., Ge, J., Zhao, D., Wang, Y., Rothwell, P. M., Gaziano, J. M., Chan, A., Burn, J., Chia, J., Langley, R., O'Donnell, V., Rocca, B., & Hawkey, C. (2018). Aspirin: 120 years of innovation. A report from the 2017 Scientific Conference of the International Aspirin Foundation, 14 September 2017,Charité, Berlin. ecancermedicalscience, 12(Feb 20), 813-820. https://doi.org/10.3332/ecancer.2018.813

@article{5d114922223a40dc9345fb7431e045bf,

title = "Aspirin: 120 years of innovation. A report from the 2017 Scientific Conference of the International Aspirin Foundation, 14 September 2017,Charit{\'e}, Berlin",

abstract = "Acetylsalicylic acid was first synthesised by Dr FeIix Hoffman on 10th August 1897 and Aspirin was born. It quickly became the best-known pain killer in the world and in the 120 years since this event, aspirin has continued to attract interest, innovation and excitement. Set within the walls of the preserved ruins of Rudolf Virchow's lecture hall at Charit{\'e}, within Berlin's Museum of Medical History, the International Aspirin Foundation's 28th Scientific Conference served to facilitate international, multi-disease, multidisciplinary discussion about the current understanding of aspirin's mechanisms of action and its utility in modern medicine as well as ideas for future research into its multifaceted applications to enhance global health.",

keywords = "Cancer Research, Lynch syndrome, Oncology, aspirin, benefit, bleeding, cardiovascular disease (CVD), colorectal cancer (CRC), individualised choice, inflammation, personalised medicine, precision medicine, primary prevention, risk, secondary prevention, stroke, tertiary prevention, Cancer Research, Lynch syndrome, Oncology, aspirin, benefit, bleeding, cardiovascular disease (CVD), colorectal cancer (CRC), individualised choice, inflammation, personalised medicine, precision medicine, primary prevention, risk, secondary prevention, stroke, tertiary prevention",

author = "Jaqui Walker and Pippa Hutchison and Junbo Ge and Dong Zhao and Yongjun Wang and Rothwell, \{Peter M.\} and Gaziano, \{J. Michael\} and Andrew Chan and John Burn and John Chia and Ruth Langley and Valerie O'Donnell and Bianca Rocca and Chris Hawkey",

year = "2018",

doi = "10.3332/ecancer.2018.813",

language = "English",

volume = "12",

pages = "813--820",

journal = "ecancermedicalscience",

issn = "1754-6605",

publisher = "ecancer Global Foundation",

number = "Feb 20",

}

Walker, J, Hutchison, P, Ge, J, Zhao, D, Wang, Y, Rothwell, PM, Gaziano, JM, Chan, A, Burn, J, Chia, J, Langley, R, O'Donnell, V, Rocca, B & Hawkey, C 2018, 'Aspirin: 120 years of innovation. A report from the 2017 Scientific Conference of the International Aspirin Foundation, 14 September 2017,Charité, Berlin', ecancermedicalscience, vol. 12, n. Feb 20, pagg. 813-820. https://doi.org/10.3332/ecancer.2018.813

TY - JOUR

T1 - Aspirin: 120 years of innovation. A report from the 2017 Scientific Conference of the International Aspirin Foundation, 14 September 2017,Charité, Berlin

AU - Walker, Jaqui

AU - Hutchison, Pippa

AU - Ge, Junbo

AU - Zhao, Dong

AU - Wang, Yongjun

AU - Rothwell, Peter M.

AU - Gaziano, J. Michael

AU - Chan, Andrew

AU - Burn, John

AU - Chia, John

AU - Langley, Ruth

AU - O'Donnell, Valerie

AU - Rocca, Bianca

AU - Hawkey, Chris

PY - 2018

Y1 - 2018

N2 - Acetylsalicylic acid was first synthesised by Dr FeIix Hoffman on 10th August 1897 and Aspirin was born. It quickly became the best-known pain killer in the world and in the 120 years since this event, aspirin has continued to attract interest, innovation and excitement. Set within the walls of the preserved ruins of Rudolf Virchow's lecture hall at Charité, within Berlin's Museum of Medical History, the International Aspirin Foundation's 28th Scientific Conference served to facilitate international, multi-disease, multidisciplinary discussion about the current understanding of aspirin's mechanisms of action and its utility in modern medicine as well as ideas for future research into its multifaceted applications to enhance global health.

AB - Acetylsalicylic acid was first synthesised by Dr FeIix Hoffman on 10th August 1897 and Aspirin was born. It quickly became the best-known pain killer in the world and in the 120 years since this event, aspirin has continued to attract interest, innovation and excitement. Set within the walls of the preserved ruins of Rudolf Virchow's lecture hall at Charité, within Berlin's Museum of Medical History, the International Aspirin Foundation's 28th Scientific Conference served to facilitate international, multi-disease, multidisciplinary discussion about the current understanding of aspirin's mechanisms of action and its utility in modern medicine as well as ideas for future research into its multifaceted applications to enhance global health.

KW - Cancer Research

KW - Lynch syndrome

KW - Oncology

KW - aspirin

KW - benefit

KW - bleeding

KW - cardiovascular disease (CVD)

KW - colorectal cancer (CRC)

KW - individualised choice

KW - inflammation

KW - personalised medicine

KW - precision medicine

KW - primary prevention

KW - risk

KW - secondary prevention

KW - stroke

KW - tertiary prevention

KW - Cancer Research

KW - Lynch syndrome

KW - Oncology

KW - aspirin

KW - benefit

KW - bleeding

KW - cardiovascular disease (CVD)

KW - colorectal cancer (CRC)

KW - individualised choice

KW - inflammation

KW - personalised medicine

KW - precision medicine

KW - primary prevention

KW - risk

KW - secondary prevention

KW - stroke

KW - tertiary prevention

UR - https://publicatt.unicatt.it/handle/10807/130498

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85044149597&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85044149597&origin=inward

U2 - 10.3332/ecancer.2018.813

DO - 10.3332/ecancer.2018.813

M3 - Article

SN - 1754-6605

VL - 12

SP - 813

EP - 820

JO - ecancermedicalscience

JF - ecancermedicalscience

IS - Feb 20

ER -

Aspirin: 120 years of innovation. A report from the 2017 Scientific Conference of the International Aspirin Foundation, 14 September 2017,Charité, Berlin

Abstract

OSS delle Nazioni Unite

All Science Journal Classification (ASJC) codes

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo